Filter News
Area of Research
News Topics
- (-) 3-D Printing/Advanced Manufacturing (3)
- (-) Biomedical (1)
- (-) Nuclear Energy (3)
- Advanced Reactors (1)
- Big Data (1)
- Bioenergy (1)
- Biology (1)
- Biotechnology (1)
- Composites (1)
- Computer Science (1)
- Coronavirus (1)
- High-Performance Computing (1)
- Isotopes (1)
- Materials (2)
- Materials Science (1)
- Nanotechnology (1)
- Neutron Science (6)
- Physics (1)
- Sustainable Energy (1)
Media Contacts
The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.
Like most scientists, Chengping Chai is not content with the surface of things: He wants to probe beyond to learn what’s really going on. But in his case, he is literally building a map of the world beneath, using seismic and acoustic data that reveal when and where the earth moves.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
Two leaders in US manufacturing innovation, Thomas Kurfess and Scott Smith, are joining the Department of Energy’s Oak Ridge National Laboratory to support its pioneering research in advanced manufacturing.
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.